Jack Nathan Medical Corp. (JNHMF)
| Previous close | 0.1561 |
| Open | 0.0675 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0675 - 0.0675 |
| 52-week range | 0.0350 - 0.2890 |
| Volume | |
| Avg. volume | 11,417 |
| Market cap | 8.1M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0770 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Jack Nathan Health to Appoint New Chief Financial Officer
TORONTO, September 20, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announces that David Berman stepped down from his position as Chief Financial Officer of the Company effective as September 19, 2022. "On behalf of myself and the board of directors, we want to thank David for his contributions to Jack Nathan Health. He has been a key contributor to our success to date, and we wish him the best in his future endeavors," said Dr. Glenn C
- Business Wire
Jack Nathan Health Announces Its Q1 Fiscal 2023 Financial Results
TORONTO, June 30, 2022--Jack Nathan Health Announces Q1-Fiscal 2023 Financial Results.
- Business Wire
Jack Nathan Health Announces Its Q4 and Year End Fiscal 2022 Financial Results
TORONTO, June 01, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2022, and fiscal year ended January 31, 2022. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
